A Multi-Component Model of Hodgkin's Lymphoma.
Hodgkin's lymphoma is an example for a tumor with an extremely tight interaction of tumor cells with cells from the tumor micro-environment. These so-called bystander cells are not inert but interact actively with the tumor cells. Some of these cells support tumor growth by delivery of co-stimulating and anti-apoptotic signals ("helper cells"). Other cells ("killer cells") are involved in the anti-tumor immune response which is obviously not efficient enough for tumor elimination. The activity of both helper cells and killer cells is regulated by additional cells in the stroma ("regulatory cells"). The dynamic behavior of such multi-component systems is difficult to predict. In the present paper we propose a model that can be used for simulation of essential features of this system. In this model, tumor growth depends on (i) presence of few cancer stem cells, (ii) co-stimulation of cancer cells by the tumor stroma, (iii) activity of regulatory cells that suppress killer cells without suppression of helper cells. The success of cytotoxic/cytostatic therapy in this model varies depending on the therapy-related toxicity for each of the cell populations. The model also allows the analysis of immunotherapeutic interventions. Under certain conditions, paradox enhancement of tumor growth can occur after therapeutic intervention. The model might be useful for the design of new treatment strategies for Hodgkin's lymphoma and other tumors with prominent tumor-stroma interaction.
Department of Pediatrics, Martin Luther University Halle-Wittenberg, Halle (S), Germany.
Martin S
MS
Staege
D017209:Apoptosis; D002453:Cell Cycle; D018450:Disease Progression; D006689:Hodgkin Disease / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D008954:Models, Biological; D012008:Recurrence; D059016:Tumor Microenvironment